Đang chuẩn bị liên kết để tải về tài liệu:
Predicting breast cancer drug response using a multiple-layer cell line drug response network model

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Predicting patient drug response based on a patient’s molecular profile is one of the key goals of precision medicine in breast cancer (BC). Multiple drug response prediction models have been developed to address this problem. |

TÀI LIỆU LIÊN QUAN

A population-based study of breast cancer prevalence in Australia: Predicting the future health care needs of women living with breast cancer

CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy

Nomogram for predicting preoperative lymph node involvement in patients with invasive micropapillary carcinoma of breast: A SEER population-based study

Value of digital mammography in predicting lymphovascular invasion of breast cancer

Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer

KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapy

Factors predicting patient satisfaction in women with advanced breast cancer: A prospective study

Development of a risk-stratification scoring system for predicting lymphovascular invasion in breast cancer

The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures

A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.